Tripos said in an 8-K filing this week that John Yingling, CFO; Richard Cramer, CSO; and Dieter Schmidt-Base, senior vice president of worldwide sales; resigned from their positions with Tripos to accept positions with Vector Capital, which completed its acquisition of the Tripos Discovery Informatics business this week (see briefs).
In addition, Tripos said that it has terminated the employment of James Rubin, senior vice president; Bryan Koontz, senior vice president of discovery informatics; and Mary Woodward, senior vice president of strategic development.
Mark Gessler has stepped down as CEO of Gene Logic. The company’s board of directors elected Charles Dimmler to replace Gessler as president and CEO. Dimmler has worked for more than 20 years in life sciences financing and has served as a director of Gene Logic since 1996.
Gessler will remain on Gene Logic’s board of directors.
Susie Stephens, formerly senior product manager for Oracle's life sciences group, has left Oracle to join Eli Lilly as a principal research scientist.